Thursday, February 13, 2025
Breakout Session - Interventional Psychiatry Frontiers
10:45 AM - 11:30 AM

This session explores the rapidly evolving landscape of ketamine treatments, transcranial magnetic stimulation (TMS) and psychedelic therapies. Experts will highlight the latest clinical advancements driving improved patient outcomes and discuss the business opportunities emerging in this innovative space. From regulatory considerations to operational strategies, this session provides a comprehensive look at how these therapies are shaping the future of behavioral health care.

Key Takeaways:

  • Learn about cutting-edge clinical advancements in ketamine, TMS and psychedelic therapies.
  • Discover business strategies and opportunities for providers in this growing field.
  • Understand the regulatory and operational challenges impacting adoption and scalability.
Kirk Manz Erin Amato, MD Brandon Kitay, MD, PhD Will Van Derveer, MD